Nektar Therapeutics will report earnings after the market closes. View Calendar The market is expecting a ±27.7% move after earnings are reported. The average move for the past 4 quarters of earnings has been ±7.4%. View Expected Move (Conf Call: Mar 4 5:00 PM)